Strengths and Limitations of Breast Cancer Risk Assessment

Kimberly Baltzell

Margaret Wrensch

ONF 2005, 32(3), 605-616. DOI: 10.1188/05.ONF.605-616

Purpose/Objectives: To evaluate current definitions of breast cancer risk and breast cancer risk assessment models, including the Gail, Claus, and BRCAPRO models, and discuss potential markers to enhance and standardize individual risk assessment.

Data Sources: Published articles, conference proceedings, and textbooks.

Data Synthesis: Defining high risk for breast cancer development is explored, and options for high-risk women are discussed. The risk factors frequently used for risk evaluation, including age, age at menarche, age at first live birth, past history of breast biopsy, family history of breast cancer, and the presence of atypical hyperplasia, are reviewed.

Conclusions: Current models of breast cancer risk assessment are limited. Exploring the progression from healthy tissue to malignancy through techniques such as fine needle aspiration, ductal lavage, and nipple aspiration may lead to more precise individualized risk prediction.

Implications for Nursing: More accurate information regarding personal breast cancer risk is necessary. Oncology nurses may facilitate the use of appropriate tools that provide the most individualized risk assessment.

Jump to a section


    Allain, D., Gilligan, M.A., & Redlich, P.N. (2002). Genetics and genetic counseling for breast cancer. In W.L. Donegan & J.S. Spratt (Eds.), Cancer of the breast (5th ed., pp. 249-268). Philadelphia: Saunders.

    Amir, E., Evans, D.G., Shenton, A., Lalloo, F., Moran, A., Boggis, C., et al. (2003). Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. Journal of Medical Genetics, 40, 807-814.

    Armstrong, K., Eisen, A., & Weber, B. (2000). Assessing the risk of breast cancer. New England Journal of Medicine, 342, 564-571.

    Baltzell, K., Eder, S., & Wrensch, M. (2005). Breast carcinogenesis: Can the examination of ductal fluid enhance our understanding? Oncology Nursing Forum, 32, 33-39.

    Begg, C.B. (2002). On the use of familial aggregation in population-based case probands for calculating penetrance. Journal of the National Cancer Institute, 94, 1221-1226.

    Bernstein, L., Henderson, B.E., Hanisch, R., Sullivan-Halley, J., & Ross, R.K. (1994). Physical exercise and reduced risk of breast cancer in young women. Journal of the National Cancer Institute, 86, 1403-1408.

    Berry, D.A., Iversen, E.S., Jr., Gudbjartsson, D.F., Hiller, E.H., Garber, J.E., Peshkin, B.N., et al. (2002). BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. Journal of Clinical Oncology, 20, 2701-2712.

    Black, W.C., Nease, R.F., Jr., & Tosteson, A.N. (1995). Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. Journal of the National Cancer Institute, 87, 720-731.

    Bondy, M.L., & Newman, L.A. (2003). Breast cancer risk assessment models: Applicability to African-American women. Cancer, 97(1, Suppl.), 230-235.

    Brinton, L.A., Lacey, J., Jr., & Devesa, S.S. (2002). Epidemiology of breast cancer. In W.L. Donegan & J.S. Spratt (Eds.), Cancer of the breast (5th ed., pp. 111-132). Philadelphia: Saunders.

    Bruzzi, P., Negri, E., La Vecchia, C., Decarli, A., Palli, D., Parazzini, F., et al. (1988). Short term increase in risk of breast cancer after full term pregnancy. BMJ, 297, 1096-1098.

    Chie, W.C., Hsieh, C., Newcomb, P.A., Longnecker, M.P., Mittendorf, R., Greenberg, E.R., et al. (2000). Age at any full-term pregnancy and breast cancer risk. American Journal of Epidemiology, 151, 715-722.

    Claus, E.B., Risch, N., & Thompson, W.D. (1993). The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Research and Treatment, 28, 115-120.

    Clemons, M., Loijens, L., & Goss, P. (2000). Breast cancer risk following irradiation for Hodgkin's disease. Cancer Treatment Reviews, 26, 291-302.

    Daly, M.B., & Ross, E.A. (2000). Predicting breast cancer: The search for a model. Journal of the National Cancer Institute, 92, 1196-1197.

    Dooley, W.C., Ljung, B.M., Veronesi, U., Cazzaniga, M., Elledge, R.M., O'Shaughnessy, J.A., et al. (2001). Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. Journal of the National Cancer Institute, 93, 1624-1632.

    Drake, D.A. (2001). A longitudinal study of physical activity and breast cancer prediction. Cancer Nursing, 24, 371-377.

    Dupont, W.D., & Page, D.L. (1985). Risk factors for breast cancer in women with proliferative breast disease. New England Journal of Medicine, 312, 146-151.

    Eeles, R.A., & Powles, T.J. (2000). Chemoprevention options for BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology, 18(21, Suppl.), 93S-99S.

    Euhus, D.M. (2001). Understanding mathematical models for breast cancer risk assessment and counseling. Breast Journal, 7, 224-232.

    Euhus, D.M., Leitch, A.M., Huth, J.F., & Peters, G.N. (2002). Limitations of the Gail model in the specialized breast cancer risk assessment clinic. Breast Journal, 8, 23-27.

    Euhus, D.M., Smith, K.C., Robinson, S., Stucky, A., Olopade, O.I., Cummings, S., et al. (2002). Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. Journal of the National Cancer Institute, 94, 844-851.

    Fabian, C.J., Kimler, B.F., Zalles, C.M., Klemp, J.R., Kamel, S., Zeiger, S., et al. (2000). Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. Journal of the National Cancer Institute, 92, 1217-1227.

    Fisher, B., Costantino, J.P., Wickerham, D.L., Redmond, C.K., Kavanah, M., Cronin, W.M., et al. (1998). Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Journal of the National Cancer Institute, 90, 1371-1388.

    Gail, M.H., Brinton, L.A., Byar, D.P., Corle, D.K., Green, S.B., Schairer, C., et al. (1989). Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. Journal of the National Cancer Institute, 81, 1879-1886.

    Goodman, A. (2002). Breast cancer risk assessment: First such guidelines created as beginning of evolving process. Oncology Times, pp. 53-54.

    Hamolsky, D., & Facione, N. (1999). Infiltrating breast cancer. In C. Miaskowski & P. Buchsel (Eds.), Oncology nursing: Assessment and clinical care (pp. 425-467). St. Louis, MO: Mosby.

    Hartmann, L.C., Schaid, D.J., Woods, J.E., Crotty, T.P., Myers, J.L., Arnold, P.G., et al. (1999). Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. New England Journal of Medicine, 340, 77-84.

    Henderson, B.E., Pike, M.C., Bernstein, L., & Ross, R.K. (1996). Breast cancer. In D. Schottenfeld & J.F. Fraumeni, Jr. (Eds.), Cancer epidemiology and prevention (2nd ed., pp. 1022-1039). New York: Oxford University Press.

    Hollingsworth, A.B., Nall, S., & Dill, D. (2002). The evolution of breast cancer risk assessment. Journal—Oklahoma State Medical Association, 95, 639-644.

    Hughes, L.E., Mansel, R.E., & Webster, D.J. (2000). Benign disorders and diseases of the breast: Concepts and clinical management (2nd ed.). London: Saunders.

    Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R.C., Ghafoor, A., et al. (2005). Cancer statistics, 2005. CA: A Cancer Journal for Clinicians, 55, 10-30.

    Kelly, P.T. (2000). Assess your true risk of breast cancer. New York: Henry Holt.

    King, E.B., Chew, K.L., Petrakis, N.L., & Ernster, V.L. (1983). Nipple aspirate cytology for the study of breast cancer precursors. Journal of the National Cancer Institute, 71, 1115-1121.

    Kushi, L., & Giovannucci, E. (2002). Dietary fat and cancer. American Journal of Medicine, 113(Suppl. 9B), 63S-70S.

    Lee, P.A., Guo, S.S., & Kulin, H.E. (2001). Age of puberty: Data from the United States of America. Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 109(2), 81-88.

    Lee, S.H., Akuete, K., Fulton, J., Chelmow, D., Chung, M.A., & Cady, B. (2003). An increased risk of breast cancer after delayed first parity. American Journal of Surgery, 186, 409-412.

    Love, R.R., Newcomb, P.A., & Trentham-Dietz, A. (2002). Prevention of breast cancer. In W.L. Donegan & J.S. Spratt (Eds.), Cancer of the breast (5th ed., pp. 199-223). Philadelphia: Saunders.

    MacDonald, D.J. (2002). Women's decisions regarding management of breast cancer risk. MedSurg Nursing, 11, 183-186.

    MacMahon, B., Cole, P., Lin, T.M., Lowe, C.R., Mirra, A.P., Ravnihar, B., et al. (1970). Age at first birth and breast cancer risk. Bulletin of the World Health Organization, 43, 209-221.

    MacMahon, B., Trichopoulos, D., Brown, J., Andersen, A.P., Cole, P., deWaard, F., et al. (1982). Age at menarche, urine estrogens, and breast cancer risk. International Journal of Cancer, 30, 427-431.

    Madigan, M.P., Ziegler, R.G., Benichou, J., Byrne, C., & Hoover, R.N. (1995). Proportion of breast cancer cases in the United States explained by well-established risk factors. Journal of the National Cancer Institute, 87, 1681-1685.

    Martin, H., & Ammerman, S.D. (2002). Adolescents with eating disorders. Primary care screening, identification, and early intervention. Nursing Clinics of North America, 37, 537-551.

    McTiernan, A., Kuniyuki, A., Yasui, Y., Bowen, D., Burke, W., Culver, J.B., et al. (2001). Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. Cancer Epidemiology, Biomarkers, and Prevention, 10, 333-338.

    Olopade, O.I., & Artioli, G. (2004). Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations. Breast Journal, 10(Suppl. 1), S5-S9.

    O'Shaughnessy, J.A. (2001). Breast cancer risk reduction: It's the standard of care. Primary Care and Cancer, 21(9), 1-2.

    Page, D.L., Vander Zwaag, R., Rogers, L.W., Williams, L.T., Walker, W.E., & Hartmann, W.H. (1978). Relation between component parts of fibro-cystic disease complex and breast cancer. Journal of the National Cancer Institute, 61, 1055-1063.

    Papanicolaou, G.N., Holmquist, D.G., Bader, G.M., & Falk, E.A. (1958). Exfoliative cytology of the human mammary gland and its value in the diagnosis of cancer and other diseases of the breast. Cancer, 11, 377-409.

    Petrakis, N.L., Barnes, S., King, E.B., Lowenstein, J., Wiencke, J., Lee, M.M., et al. (1996). Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiology, Biomarkers, and Prevention, 5, 785-794.

    Rosen, P.P. (2001). Rosen's breast pathology (2nd ed.). Philadelphia: Lippincott Williams and Wilkins.

    Sakorafas, G.H., Krespis, E., & Pavlakis, G. (2002). Risk estimation for breast cancer development: A clinical perspective. Surgical Oncology, 10(4), 183-192.

    Sartorius, O.W., Smith, H.S., Morris, P., Benedict, D., & Friesen, L. (1977). Cytologic evaluation of breast fluid in the detection of breast disease. Journal of the National Cancer Institute, 59, 1073-1080.

    Singletary, S.E. (2003). Rating the risk factors for breast cancer. Annals of Surgery, 237, 474-482.

    Tyrer, J., Duffy, S.W., & Cuzick, J. (2004). A breast cancer prediction model incorporating familial and personal risk factors. Statistics in Medicine, 23, 1111-1130.

    Verp, M.S., Cummings, S.A., & Olopade, O.I. (2001). Cancer genetics in the clinic. In M. Mahowald, A. Scheuerle, V. McKusick, & T. Aspinwall (Eds.), Genetics in the clinic: Clinical, ethical, and social implications (pp. 41-58). St. Louis, MO: Mosby.

    Webber, W., & Boyd, N. (1986). A critique of the methodology of studies of benign breast disease and breast cancer risk. Journal of the National Cancer Institute, 77, 397-404.

    Winer, E., Morrow, M., Osborne, C., & Harris, J. (2001). Malignant tumors of the breast. In V. Devita, S. Hellman, & S. Rosenberg (Eds.), Cancer: Principles and practice of oncology (6th ed., pp. 1651-1716). Phildelphia: Lippincott Williams and Wilkins.

    Wrensch, M.R., Petrakis, N.L., King, E.B., Lee, M.M., & Miike, R. (1993). Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluid and prior history of breast biopsy. American Journal of Epidemiology, 137, 829-833.

    Wrensch, M.R., Petrakis, N.L., King, E.B., Miike, R., Mason, L., Chew, K., et al. (1992). Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid. American Journal of Epidemiology, 135, 130-141.

    Wrensch, M.R., Petrakis, N.L., Miike, R., King, E.B., Chew, K., Neuhaus, J., et al. (2001). Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. Journal of the National Cancer Institute, 93, 1791-1798.